THE TINY BLOOD TEST

WIPO WIPO 2015

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke THE TINY BLOOD TEST wurde als Wortmarke am 12.10.2015 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 23. August 2018

Markenform Wortmarke
Aktenzeichen 1288637
Länder Australien Schweiz China Europäische Gemeinschaft Israel Indien Japan Südkorea Mexiko Norwegen Philippinen Russland Singapur
Basismarke US Nr. 86594738, 12. April 2015
Anmeldedatum 12. Oktober 2015
Ablaufdatum 01. Januar 2018

Markeninhaber

1701 Page Mill Road
Palo Alto, CA 94304
US

Markenvertreter

801 California Street, Silicon Valley Center US

Waren und Dienstleistungen

01 Reagents for scientific or research use; chemical preparations for scientific purposes; reagents for chemical analysis; diagnostic preparations for scientific or research use; genetic identity tests comprised of reagents; antibodies for in vitro scientific or research use; biochemicals; biomedical compounds for scientific or research use; chemical preparations to be used in biochemical and clinical research
05 Biological and chemical preparations for medical or veterinary use; reagents and media for medical or veterinary purposes; clinical medical reagents; biological and chemical preparations, namely, antibodies for clinical, medical or veterinary use to detect and analyze substances; diagnostic substances for medical or veterinary use; diagnostic preparations for medical or veterinary purposes; diagnostic testing materials for bodily fluids; medical diagnostic test kits comprised of reagents and assays for testing of body fluids; medical diagnostic and monitoring test strips for use in the treatment of a wide variety of diseases and health disorders; test strips for medical and laboratory analysis of blood; preparations for predicting ovulation; biological tissue cultures for medical or veterinary purposes; culture media for cultivating blood cells; diagnostic reagents for clinical or medical laboratory use; testing materials containing reagents used in analyzing and detecting certain toxins for clinical or medical laboratory use; diagnostic preparations for clinical or medical laboratory use
09 Computer software for healthcare monitoring; computer software for communicating medical test results to patients; computer software for communicating medical test results to service providers in the medical and healthcare fields; computer software for scheduling a laboratory test appointment; computer software for appointment scheduling; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for use in biomonitoring of humans and of animals; computer software for medical monitoring and analysis of medical data; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; mobile electronic devices, namely, tablet computers, mobile phones, personal digital assistants, and other cellular or wireless communication devices; downloadable electronic publications, namely, downloadable newsletters, blogs, e-zines, magazines, books, manuals, pamphlets, diaries and journals in the fields of healthcare, medicine, personal health and fitness, biomonitoring, medical diagnostics, monitoring and testing
10 Medical devices; medical devices, namely, point of care and handheld devices for analysis of drugs, proteins and other substances, and wireless transfer of medical data; medical measuring apparatus; medical measuring apparatus, namely, cartridges for use with therapies or equipment for medical monitoring and analysis of substances; apparatus for blood analysis; apparatus for taking blood samples; blood testing apparatus; apparatus for clinical diagnosis; capillary reagent tubes; capillary tubes for blood; capillary tubes for samples; containers especially made for processing blood samples; containers for medical waste; devices for monitoring blood sugar; diagnostic apparatus for the detection of a wide variety of diseases; health monitoring devices; medical diagnostics apparatus; medical apparatus and instruments for monitoring blood properties; medical devices for obtaining body fluid samples; patient medical monitors for monitoring a wide variety of physical conditions and diseases
35 Administering pharmacy reimbursement programs and services; administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; business administration relating to medical referrals; business administration relating to physician referrals; medical billing support services; administrative management of an internet-based database relating to patient medical information designed to facilitate sharing, and maintenance of data in computer databases relating to patient medical information between and amongst the patient and healthcare professionals providing services to the patient; maintaining patient medical records and files
36 Insurance claims processing; financial management relating to pharmaceutical benefits; financial management relating to pharmacy benefits; financial management relating to medical laboratory benefits
42 Medical and scientific research services in the fields of blood analysis health care and health care monitoring; pharmaceutical research services; pharmaceutical research and development; blood analysis services; chemical laboratories; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; genetic testing of laboratory animals for research purposes; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical research laboratories; medical research laboratory services; providing laboratory research services in the field of gene expression, namely, cancer biology; rental of laboratory apparatus and instruments; scientific laboratory services; providing information, via a web site, featuring technology that enables patients, physicians and other healthcare providers to generate, manage and exchange medical information
44 Medical evaluation services; medical evaluation services, namely, assessment of patients undergoing medical treatment; medical monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; collection and preservation of human and animal blood; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; drug, alcohol and DNA screening for medical purposes; health assessment services; health care; medical counseling; medical information; medical screening; medical services; medical testing for diagnostic or treatment purposes; providing information in the field of pet health; pet hospital services; provision of medical information from a website; provision of health and healthcare information via a website; internet-based health care information services; providing health information; providing healthcare information; rental of medical equipment; veterinary special services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
05. Juli 2018 2018/34 Gaz US RAW: Total Ceasing Effect
18. Januar 2018 2018/5 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
15. Januar 2018 2018/3 Gaz AU Ablehnung
09. Januar 2018 2018/3 Gaz IL Ablehnung
14. Dezember 2017 2017/51 Gaz MX RAW: Rule 18ter(2)(ii) GP following a provisional refusal
08. September 2017 2017/44 Gaz RAW: Limitation
18. August 2017 2017/39 Gaz RU Ablehnung
29. Juni 2017 2017/26 Gaz MX Ablehnung
22. Juni 2017 2017/27 Gaz IL Ablehnung
14. Juni 2017 2017/24 Gaz CH RAW: Rule 18ter(2)(i) GP following a provisional refusal
25. Mai 2017 2017/22 Gaz CN Ablehnung
06. März 2017 2017/10 Gaz KR Ablehnung
20. Februar 2017 2017/9 Gaz IN Ablehnung
25. Januar 2017 2017/5 Gaz RU Ablehnung
18. Januar 2017 2017/23 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
06. Januar 2017 2017/5 Gaz CH Ablehnung
06. Oktober 2016 2016/42 Gaz JP Ablehnung
19. September 2016 2016/39 Gaz KR Ablehnung
04. August 2016 2016/33 Gaz PH Ablehnung
08. Juli 2016 2016/31 Gaz NO Ablehnung
25. Mai 2016 2016/24 Gaz SG Ablehnung
11. März 2016 2016/12 Gaz AU Ablehnung
29. Februar 2016 2016/12 Gaz EM Ablehnung
12. Oktober 2015 2016/6 Gaz US Eintragung

ID: 141288637